Live Breaking News & Updates on Regulus therapeutics

Stay informed with the latest breaking news from Regulus therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Regulus therapeutics and stay connected to the pulse of your community

Regulus Therapeutics Inc. (NASDAQ:RGLS) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month […]

United-states , Canaccord-genuity-group , Regulus-therapeutics-inc , Nasdaq , Hermes-inc , Exome-asset-management , Wells-fargo-company , Vanguard-group-inc , Regulus-therapeutics-company-profile , Victory-capital-management-inc , Regulus-therapeutics

Stock Analysts' New Coverage for April 8th (AACG, AAME, ADXS, AKTX, AMED, AMT, AP, APWC, ARTW, AVGR)

Stock Analysts’ new coverage for Monday, April 8th: StockNews.com began coverage on shares of ATA Creativity Global (NASDAQ:AACG). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). The […]

China , Xinyuan , Sichuan , Canada , United-states , Canadian , American , Craig-hallum , William-blair , Ayala-pharmaceuticals , Willamette-valley-vineyards , Nasdaq

Regulus Therapeutics (NASDAQ:RGLS) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a report issued on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research analysts have also recently commented on RGLS. SVB Leerink assumed coverage on Regulus Therapeutics in a research report on Monday, March […]

United-states , Leerink-partnrs , Prelude-capital-management , Dimensional-fund-advisors , Canaccord-genuity-group , Wells-fargo-company , Regulus-therapeutics-inc , Renaissance-technologies , Commonwealth-equity-services , Blackrock-inc , Regulus-therapeutics-company-profile , Regulus-therapeutics

StockNews.com Initiates Coverage on Regulus Therapeutics (NASDAQ:RGLS)

StockNews.com Initiates Coverage on Regulus Therapeutics (NASDAQ:RGLS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Leerink-partnrs , Wells-fargo-company , Nasdaq , Canaccord-genuity-group , Victory-capital-management-inc , Regulus-therapeutics-inc , Exome-asset-management , Regulus-therapeutics-company-profile , Prelude-capital-management , Renaissance-technologies , Regulus-therapeutics

Regulus Therapeutics (NASDAQ:RGLS) Research Coverage Started at StockNews.com

Regulus Therapeutics (NASDAQ:RGLS) Research Coverage Started at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Leerink-partnrs , Regulus-therapeutics-inc , Commonwealth-equity-services , Canaccord-genuity-group , Northern-trust-corp , Prelude-capital-management , Dimensional-fund-advisors , Regulus-therapeutics-company-profile , Wells-fargo-company , Renaissance-technologies , Regulus-therapeutics

HC Wainwright Reaffirms "Buy" Rating for Regulus Therapeutics (NASDAQ:RGLS)

HC Wainwright Reaffirms "Buy" Rating for Regulus Therapeutics (NASDAQ:RGLS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Leerink-partnrs , Nasdaq , Regulus-therapeutics-company-profile , Regulus-therapeutics-inc , Prelude-capital-management , Renaissance-technologies , Canaccord-genuity-group , Northern-trust-corp , Dimensional-fund-advisors , Wells-fargo-company , Commonwealth-equity-services

Regulus Therapeutics (NASDAQ:RGLS) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reiterated their buy rating on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a research report released on Monday morning, Benzinga reports. The brokerage currently has a $9.00 target price on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Regulus Therapeutics’ Q1 2024 earnings at ($0.19) EPS, Q2 2024 earnings […]

United-states , Leerink-partnrs , Exome-asset-management , Canaccord-genuity-group , Regulus-therapeutics-inc , Wells-fargo-company , Vanguard-group-inc , Hermes-inc , Victory-capital-management-inc , Regulus-therapeutics , Free-report , Genuity-group

Short Interest in Regulus Therapeutics Inc. (NASDAQ:RGLS) Expands By 9,244.3%

Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 5,130,000 shares, an increase of 9,244.3% from the February 29th total of 54,900 shares. Based on an average daily volume of 2,870,000 shares, the days-to-cover ratio is currently 1.8 […]

United-states , Leerink-partnrs , Hermes-inc , Regulus-therapeutics-inc , Vanguard-group-inc , Wells-fargo-company , Nasdaq , Canaccord-genuity-group , Exome-asset-management , Victory-capital-management-inc , Regulus-therapeutics , Get-free-report

Regulus Therapeutics (NASDAQ:RGLS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a research report report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. RGLS has been the subject of a number of other reports. Leerink Partnrs reaffirmed an outperform rating on shares of Regulus Therapeutics in a […]

United-states , Leerink-partnrs , Dimensional-fund-advisors , Victory-capital-management-inc , Commonwealth-equity-services , Regulus-therapeutics-company-profile , Regulus-therapeutics-inc , Canaccord-genuity-group , Wells-fargo-company , Blackrock-inc , Nasdaq , Renaissance-technologies

Research Analysts' Recent Ratings Updates for Regulus Therapeutics (RGLS)

Regulus Therapeutics (NASDAQ: RGLS) has recently received a number of price target changes and ratings updates: 3/25/2024 – Regulus Therapeutics had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock. 3/23/2024 – Regulus Therapeutics is now covered by analysts at StockNews.com. They set a “hold” […]

United-states , Leerink-partnrs , News-ratings-for-regulus-therapeutics-inc-daily , Dimensional-fund-advisors , Regulus-therapeutics-inc , Northern-trust-corp , Commonwealth-equity-services , Wells-fargo-company , Prelude-capital-management , Renaissance-technologies , Canaccord-genuity-group-inc , Regulus-therapeutics